On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients

<p> T.A. Morozova </p> <p> The Cheboksary Branch Of Svyatoslav Fyodorov Eye Microsurgery Federal State Institution Ministry Of Health Of The Russian Federation, Cheboksary, Russian Federation </p> <p> <br> </p> <p> This article aims to review th...

Full description

Saved in:
Bibliographic Details
Main Author: T.A. Morozova
Format: Article
Language:Russian
Published: Prime-Media 2023-03-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/cbb/e74y88j4mkkubtnxrp7rtmjjxavq89mi.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841526899957825536
author T.A. Morozova
author_facet T.A. Morozova
author_sort T.A. Morozova
collection DOAJ
description <p> T.A. Morozova </p> <p> The Cheboksary Branch Of Svyatoslav Fyodorov Eye Microsurgery Federal State Institution Ministry Of Health Of The Russian Federation, Cheboksary, Russian Federation </p> <p> <br> </p> <p> This article aims to review the up-to-date approaches to the control of a non-specific inflammatory response following cataract phacoemulsification with intraocular lens implantation. The authors highlight the key objectives of using nonsteroidal anti-inflammatory agents after cataract surgery during the entire postoperative period, primarily to control inflammatory response and pain and to reduce the risk of cystoid macular edema. The article presents a wide range of data on the outcomes of using various nonsteroidal anti-inflammatory drugs (NSAIDs) in postoperative patients. Over the past years, classical approaches to the selection of patient management schemes have been revised taking into consideration findings of the numerous multicenter trials constructed on the principles of evidence-based medicine. The authors provide rationale for the selection of an optimal anti-inflammatory drug underpinned by the clinical trial results, pharmacodynamic and pharmacokinetic&nbsp; parameters of NSAIDs of a new generation. The emphasis is made on the use of bromfenac in patients with cataract. In addition, the risk factors and the major strategies of prevention and treatment of macular edema following surgical procedures are reviewed, including those in patients with diabetes mellitus. </p> <p> <b>Keywords</b>: cataract surgery, cystoid macular edema, NSAID, bromfenac, diabetes mellitus, perioperative period. </p> <p> <b>For citation:</b> Morozova T.A. On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients. Russian Journal of Clinical Ophthalmology. 2023;23(1):54–59 (in Russ.). DOI: 10.32364/2311-7729-2023-23-1-54-59. </p>
format Article
id doaj-art-a0406c4593574838a6812499b55a4da8
institution Kabale University
issn 2311-7729
2619-1571
language Russian
publishDate 2023-03-01
publisher Prime-Media
record_format Article
series РМЖ "Клиническая офтальмология"
spelling doaj-art-a0406c4593574838a6812499b55a4da82025-01-16T09:39:37ZrusPrime-MediaРМЖ "Клиническая офтальмология"2311-77292619-15712023-03-0123131567On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patientsT.A. Morozova0Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> T.A. Morozova </p> <p> The Cheboksary Branch Of Svyatoslav Fyodorov Eye Microsurgery Federal State Institution Ministry Of Health Of The Russian Federation, Cheboksary, Russian Federation </p> <p> <br> </p> <p> This article aims to review the up-to-date approaches to the control of a non-specific inflammatory response following cataract phacoemulsification with intraocular lens implantation. The authors highlight the key objectives of using nonsteroidal anti-inflammatory agents after cataract surgery during the entire postoperative period, primarily to control inflammatory response and pain and to reduce the risk of cystoid macular edema. The article presents a wide range of data on the outcomes of using various nonsteroidal anti-inflammatory drugs (NSAIDs) in postoperative patients. Over the past years, classical approaches to the selection of patient management schemes have been revised taking into consideration findings of the numerous multicenter trials constructed on the principles of evidence-based medicine. The authors provide rationale for the selection of an optimal anti-inflammatory drug underpinned by the clinical trial results, pharmacodynamic and pharmacokinetic&nbsp; parameters of NSAIDs of a new generation. The emphasis is made on the use of bromfenac in patients with cataract. In addition, the risk factors and the major strategies of prevention and treatment of macular edema following surgical procedures are reviewed, including those in patients with diabetes mellitus. </p> <p> <b>Keywords</b>: cataract surgery, cystoid macular edema, NSAID, bromfenac, diabetes mellitus, perioperative period. </p> <p> <b>For citation:</b> Morozova T.A. On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients. Russian Journal of Clinical Ophthalmology. 2023;23(1):54–59 (in Russ.). DOI: 10.32364/2311-7729-2023-23-1-54-59. </p>http://clinopht.com/upload/iblock/cbb/e74y88j4mkkubtnxrp7rtmjjxavq89mi.pdf
spellingShingle T.A. Morozova
On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients
РМЖ "Клиническая офтальмология"
title On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients
title_full On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients
title_fullStr On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients
title_full_unstemmed On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients
title_short On the optimal selection of nonsteroidal anti-inflammatory drugs in the management scheme of cataract patients
title_sort on the optimal selection of nonsteroidal anti inflammatory drugs in the management scheme of cataract patients
url http://clinopht.com/upload/iblock/cbb/e74y88j4mkkubtnxrp7rtmjjxavq89mi.pdf
work_keys_str_mv AT tamorozova ontheoptimalselectionofnonsteroidalantiinflammatorydrugsinthemanagementschemeofcataractpatients